Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cortexyme Inc
(NQ:
CRTX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jul 29, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cortexyme Inc
< Previous
1
2
3
4
5
Next >
Cortexyme Selects 3CLpro Inhibitor As COVID-19 Candidate
July 23, 2021
Cortexyme Inc (NASDAQ: CRTX) has selected COR803 to further evaluate for coronavirus infections, including COVID-19 disease. COR803 is a novel patent-pending small...
Via
Benzinga
Exposures
COVID-19
Cortexyme Announces Lead 3CLpro Inhibitor for the Treatment of Coronavirus Infection
July 23, 2021
From
Cortexyme, Inc.
Via
Business Wire
The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, AbSci IPO
July 22, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 21) Biohaven Pharmaceutical...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs
July 23, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 22) Bio-Techne Corporation (...
Via
Benzinga
Cortexyme to Present New Data at AAIC 2021
July 22, 2021
From
Cortexyme, Inc.
Via
Business Wire
Cortexyme Presents New Data Demonstrating Atuzaginstat Disrupts Biofilms and is Efficacious in Preclinical Models of Periodontal Disease at IADR 2021
July 21, 2021
From
Cortexyme, Inc.
Via
Business Wire
Cortexyme to Host Symposium at AAIC 2021
July 19, 2021
From
Cortexyme, Inc.
Via
Business Wire
Biogen Stock Drags On Alzheimer's Players As FDA Requests Review Of Aduhelm Approval
July 09, 2021
Biogen stock tumbled Friday after the FDA requested an independent review of the process that led to its recent Alzheimer's approval.
Via
Investor's Business Daily
Exposures
Product Safety
Cortexyme to Host Two-Part Key Opinion Leader Webinar Series on Atuzaginstat
July 08, 2021
From
Cortexyme, Inc.
Via
Business Wire
The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs
June 25, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 24) AngioDynamics, Inc. (NASDAQ...
Via
Benzinga
Exposures
COVID-19
Biogen Snagged: Will Hefty Price Tag Hinder Alzheimer's Drug Use?
June 08, 2021
Biogen stock dipped Tuesday as analysts questioned how much use its potential blockbuster Alzheimer's treatment, Aduhelm, would ultimately secure.
Via
Investor's Business Daily
Biogen Wins Landmark Alzheimer's Approval: 5 Things To Know About Aducanumab
June 07, 2021
The FDA approved Biogen's Alzheimer's treatment, aducanumab, on Monday — though Biogen stock remained halted into the long-awaited decision.
Via
Investor's Business Daily
Exposures
Product Safety
Cortexyme Presents Updated Baseline Data from Complete Set of Participants Enrolled in Pivotal GAIN Trial at ASCP 2021 Annual Meeting
June 01, 2021
From
Cortexyme, Inc.
Via
Business Wire
Cortexyme to Present at Investor Conferences in June 2021
May 26, 2021
From
Cortexyme, Inc.
Via
Business Wire
The Fight Against Alzheimer's Reaches A Moment Of Truth For Biogen, Other Biotech Stocks
May 21, 2021
The FDA will soon review aducanumab, possibly the first new Alzheimer's treatment in years. Stakes are high for Biogen stock — and other biotech stocks too.
Via
Investor's Business Daily
Exposures
Product Safety
Cortexyme Provides Business Update and Reports First Quarter 2021 Results
May 10, 2021
From
Cortexyme, Inc.
Via
Business Wire
Cortexyme to Present at the BofA Securities 2021 Healthcare Conference on May 11, 2021
May 04, 2021
From
Cortexyme, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.